Similar articles

• Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial.

  Brown MJ, McInnes GT, Papst CC, Zhang J, MacDonald TM. Brown MJ, et al. Lancet. 2011 Jan 22;377(9762):312-20. doi: 10.1016/S0140-6736(10)62003-X. Epub 2011 Jan 12. Lancet. 2011. PMID: 21236483 Clinical Trial.
• Editorial: aliskiren/amlodipine single-pill combinations: more evidence in favour of combination formulations for the treatment of hypertension.

  Katsiki N, Athyros VG, Mikhailidis DP, Karagiannis A. Katsiki N, et al. Curr Vasc Pharmacol. 2012 Nov;10(6):745-7. doi: 10.2174/157016112803520783. Curr Vasc Pharmacol. 2012. PMID: 23113710
• Combined aliskiren-amlodipine treatment for hypertension in African Americans: clinical science and management issues.

  Izzo JL, Zion AS. Izzo JL, et al. Ther Adv Cardiovasc Dis. 2011 Jun;5(3):169-78. doi: 10.1177/1753944711409615. Epub 2011 May 23. Ther Adv Cardiovasc Dis. 2011. PMID: 21606125 Review.
• [A powerful duo: antihypertensives aliskiren and amlodipine in one tablet. Combination tablet for hypertensive patients with diabetes and overweight].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2011 May 12;153(19):42-3. MMW Fortschr Med. 2011. PMID: 21612097 German. No abstract available.
• Aliskiren/valsartan (Valturna) for hypertension.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Nov 30;51(1326):94-5. Med Lett Drugs Ther. 2009. PMID: 20224524 Review. No abstract available.